1. Home
  2. VALN vs RGR Comparison

VALN vs RGR Comparison

Compare VALN & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$5.70

Market Cap

582.2M

Sector

Health Care

ML Signal

N/A

Logo Sturm Ruger & Company Inc.

RGR

Sturm Ruger & Company Inc.

N/A

Current Price

$43.56

Market Cap

601.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VALN
RGR
Founded
2012
1949
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
582.2M
601.9M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
VALN
RGR
Price
$5.70
$43.56
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$12.25
★ $43.00
AVG Volume (30 Days)
21.9K
★ 216.8K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
★ 1.05%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.44
Revenue
N/A
★ $546,057,000.00
Revenue This Year
N/A
$6.89
Revenue Next Year
$87.65
$1.61
P/E Ratio
★ N/A
$99.11
Revenue Growth
N/A
★ 1.94
52 Week Low
$4.75
$28.33
52 Week High
$12.18
$48.21

Technical Indicators

Market Signals
Indicator
VALN
RGR
Relative Strength Index (RSI) 39.99 66.12
Support Level $5.10 $36.79
Resistance Level $6.60 $44.00
Average True Range (ATR) 0.20 0.87
MACD -0.08 0.07
Stochastic Oscillator 23.73 66.75

Price Performance

Historical Comparison
VALN
RGR

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: